Multispecific antibody targeting HIV gp120 protein and human CD3 molecule and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 珠海臻谱基因科技有限公司
- Publication Date
- 2022-06-07
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of immunoglobulin, in particular to a multispecific antibody targeting HIV gp120 protein and human CD3 molecule and its application. Background technique
[0002] Acquired Immune Deficiency Syndrome (AIDS), also known as AIDS, is caused by infection with Human Immunodeficiency Virus (HIV). HIV can destroy the human immune system, the most important CD4 in the human immune system + T lymphocytes as the main target of attack, a large number of destruction of the cells, so that the body loses immune function. Therefore, the human body is easily infected with various diseases, and malignant tumors can occur, and the mortality rate is high. HIV invades CD4 + When T cells are used, the CD4 molecule on the cell surface is the main receptor, and CCR5 or CXCR4 is the coreceptor. In the first step of infection, the virus gets close to the cell through the binding of its outer membrane protein gp120 to the CD4 molecu...